Background and Objective: This study compares hospital costs and clinical outcomes for conventional laparoscopic, single-port, and mini-laparoscopic cholecystectomy from US hospitals.
INTRODUCTION
Cholecystectomy is one of the most frequently performed abdominal surgery procedures in the United States, with Ͼ750,000 cholecystectomies performed laparoscopically each year. 1, 2 Laparoscopic cholecystectomy evolved from surgical attempts to improve patient outcomes, including postoperative morbidity, cosmetic results, hospital length of stay, and duration of convalescence. [3] [4] [5] Continued attempts to improve these outcomes have led to the development of alternatives to conventional laparoscopic cholecystectomy (CLC), including micro-or mini-laparoscopic cholecystectomy (MLC) and, more recently, single-port cholecystectomy surgery (SPS). 6 However, understanding the effect of these emerging techniques on clinical and economic outcomes is critical to guiding practice patterns, clinical guidelines, and payor decisions.
SPS is a technical departure from CLC in that it uses a single, transabdominal incision rather than multiple incisions for trocar insertion. 7, 8 This procedure is typically performed with several trocars spaced closely together or with a multi-instrument port. [7] [8] [9] MLC is performed by use of percutaneous instrumentation or trocars that are significantly smaller in size than those used in conventional laparoscopic procedures. The procedure was primarily developed to reduce incisional pain.
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Studies have reported improvements in cosmetic outcome, pulmonary function, and overall satisfaction. 10 -14 One small study did report that up to 38% of patients (5 of 13) required conversion from MLC to CLC. 10 The purpose of this article is a cost comparison of cholecystectomy approaches including conventional, singleport, and mini-laparoscopic surgeries. We performed our analysis using the Premier Hospital Database as a source of cost from the hospital perspective.
METHODS
A protocol describing the analysis objectives, criteria for patient selection, data elements of interest, and statistical methods was submitted to the New England Institutional Review Board, and exemption was obtained (No. 11-240).
Data Source
The Premier Hospital Database, which contains clinical and utilization information on patients receiving care in 442 hospitals and ambulatory surgery centers across the United States during the period of interest, was used. Specifically, this database contains complete patient billing, hospital cost, and coding histories from more than 25 million inpatient discharges and 175 million hospital outpatient visits. 15 Data for 2009 through the second quarter of 2010 were used and anonymized with regard to patient identifiers.
Patients and Procedures
Eligible patients were those aged Ն18 years undergoing an outpatient laparoscopic cholecystectomy. International Classification of Diseases, Ninth Revision and Current Procedural Terminology codes for identifying the laparoscopic cholecystectomy, diagnosis codes for identifying patient comorbid conditions, and all adverse events are listed in Appendices A, B, and C, respectively.
Eligible patients with procedure codes identifying a laparoscopic cholecystectomy were then subdivided into 3 mutually exclusive groups: CLC, SPS, or MLC. Hospital charge descriptions for the surgical tools used were text mined to identify SPS procedures. The distinction between MLC and CLC was based on the size of the surgical instrument. MLC was defined by records of no SPS products identified in the charge master descriptions, record of at least 1 product Ͻ5 mm used; not more than 1 product Ͼ5 mm used, and any other products identified equaled 5 mm. Procedures that were not identified as SPS or MLC were considered CLC procedures.
Statistical Analyses
Initial counts, percentages, means, and standard deviations for demographics, comorbid conditions, hospital characteristics, safety, and cost outcomes were summarized for CLC, SPS, and MLC by use of descriptive statistics for patients in the outpatient setting. Safety outcomes of interest were selected from adverse events occurring during or up to 30 days after surgery. Cost outcomes were total hospital costs per patient, both fixed and variable.
Because the sample size for the SPS group was very limited in the inpatient setting, univariate and multivariable analyses were performed on outpatient procedures only. Furthermore, by examining patients in the outpatient setting only, it was possible to analyze a more homogeneous patient population.
Multivariable logistic regression analyses were run for binary outcomes, such as adverse events. Ordinary least squares regressions were used for the continuous outcome of hospital costs. For all models, the following explanatory variables were included: age, sex, race, marital status, insurance type, comorbid conditions (e.g., diabetes), census region of the hospital, rural versus urban hospitals, teaching versus nonteaching hospitals, and number of hospital beds. By use of these explanatory variables, multivariable models were estimated to isolate the effects of SPS versus CLC, SPS versus MLC, and MLC versus CLC on hospital costs. To eliminate cost outliers, both the upper 0.5% and lower 0.5% of costs were set to missing values. In addition to the trimming of outliers, a natural-log transformation of the costs was used as the dependent variable in multivariate models. Smearing estimates were then used to avoid the introduction of bias when we converted back to the untransformed dollar scale. 16 All analyses were performed with SAS software, version 9.2 (SAS Institute, Cary, NC, USA).
RESULTS
There were a total of 193,014 eligible laparoscopic cholecystectomy procedures identified in the database from the period from the first quarter of 2009 through the second quarter of 2010. A patient attrition diagram is shown in Figure 1 . The majority of all procedures (59%, 116,823 of 196,628) were performed in the outpatient setting, with 98% (114,356) of these patients undergoing a CLC. For the remaining 2% of outpatient procedures (2,467), 527 SPS procedures and 1,940 MLC procedures were identified. As summarized in Table 1 , characteristics of eligible outpatient procedures show that there were substantially more women than men, with rates for both dropping off after age 50 years. Regarding insurance, more patients had managed care than government or other sources of insurance. In the outpatient setting, the 3 procedure groups (SPS, MLC, and CLC) appear to be very well balanced overall in terms of patient demographics.
The distribution of patient comorbidities is shown in Table 2 and suggests a lower percentage of comorbidities overall in the SPS population, with the rates of many of the conditions as low as half of the rates in the other cohorts. Hypertension was the most common comorbid condition across all 3 groups.
Unadjusted Analysis
The cholecystectomies studied were performed in 428 hospitals. Most procedures, as well as most patients, derived from urban, nonteaching, moderate-to largesized hospitals in the South. 15 As noted earlier for the overall patient population, hospital characteristics were well balanced across all 3 surgical cohorts (CLC, MLC, and SPS).
All adverse events are reported in Table 3 . Events are subdivided into 5 categories: procedure related, systemic, other events, death, and bleeding. The most common complications were in the category of other events and included abdominal rigidity/tenderness, digestive system complications, gastroparesis paralytic ileus, nausea and vomiting, operative complications, and peritonitis. The overall adverse event rate was higher for SPS (12%) than for MLC (6%) and CLC (6%), with most of the events in all 3 groups falling into the "other events" category. The procedure-related systemic events, death and bleeding, were very infrequent (Ͻ0.5%) for all 3 groups. 
Adjusted Analysis
The results of adjusted analyses of costs and complication rates are shown in 
DISCUSSION
This retrospective analysis of a large, nationally representative database of hospitals and procedures found that patients undergoing SPS had higher adverse event rates than those undergoing MLC or CLC. The analysis also showed that SPS was associated with higher adjusted hospital outpatient costs than CLC but that MLC, when performed in this setting, was the least expensive. These findings are somewhat consistent with a recent review of SPS, which also raised concerns about the safety of the procedure, and a recent meta-analysis of primarily MLC procedures, which found similar rates of adverse events compared with patients undergoing CLC. 17, 18 Clinical Implications
Innovations in the surgical approach to performing cholecystectomy represent an important potential pathway to improving patient outcomes. The development and diffusion of laparoscopic cholecystectomy to the United States that began more than 20 years ago heralded a reduction in postoperative mortality rates and days of convalescence for patients who would have otherwise been treated with open cholecystectomy. 2 This pattern of innovation continues with both SPS and MLC. However, continued improvements in patient outcomes can only be ensured with careful attention to the comparative effectiveness of these procedures relative to CLC, which constitutes most cholecystectomies currently performed in developed countries. 19 Adverse event rates in patients undergoing cholecystectomy in outpatient hospital centers were highest in patients treated with SPS compared with MLC and CLC and were comparable between patients treated with MLC and those treated with CLC. This difference appears to be driven by higher rates of bile duct obstruction, digestive system complications, gastroparesis, paralytic ileus, postoperative nausea and vomiting, and operative complications in the SPS population. The incidence of serious adverse events, including bile duct injury, thromboembolic events (including stroke and myocardial infarction), and hemorrhage, was low across all proce- dures and did not appear to be substantially different in patients undergoing SPS.
Economic Implications
Adjusted hospital outpatient costs were highest in patients undergoing SPS: SPS cost 18% more than MLC and 18% more than CLC, with a difference of $834 and $964, respectively ( Table 5 ). The analyses also showed that MLC was associated with the lowest hospital costs. It is likely that the differences in adverse event rates detailed earlier contributed to the cost differences.
Because otherwise healthy patients with reliable home support can leave the hospital within 6 hours of undergoing cholecystectomy, outpatient models of cholecystectomy are increasingly used. 20 The sources of variation in costs of cholecystectomy procedures performed in an outpatient setting should be explored further in future studies, but these findings of statistically significant differences between the cost of SPS and the cost of MLC or CLC may have important implications with regard to the cost of the procedure to the hospital or outpatient facility. With approximately 750,000 laparoscopic cholecystectomies performed in the United States each year, any differences in procedure-related costs or savings could be significant and realizable. 1,2
Limitations
This analysis was limited by the lack of more detailed information about patients and procedures. For instance, it would have been of interest to examine the influence of additional patient characteristics, such as weight or body mass index, and more procedure-related details. In the future, this may be possible as clinically rich datasets become available from greater use of electronic medical records in hospital settings, thereby facilitating analyses in these directions.
The analyses of adverse event rates and the specific types of complications constituting these rates in patients undergoing SPS were also limited by a small sample size, particularly compared with the number of patients in the database who underwent MLC or CLC. Surgeon experience is a well-established predictor of the overall inci- dence of laparoscopic complications, and we were unable to adjust for this important variable. 21, 22 The available data will likely become more robust over time as procedure volume increases.
Even without access to the additional clinical detail available in electronic medical records, the Premier Hospital Database provides a strong basis for this analysis, given the very large numbers of patients and procedures that it provides, as well as the nationwide scope it represents. 15 Thus the cost of each procedure was based on costs across the Premier network. This analysis found MLC to have a statistically lower cost to the hospital in comparison with CLC. The reasons for these differences were not ascertained, and further study to understand these differences would be of interest.
CONCLUSION
The analysis of a large, nationally representative hospital claims database provides evidence that, in the outpatient setting, SPS costs approximately 18% more than MLC and CLC. Mini-laparoscopic surgery costs approximately 5% less than traditional laparoscopy. Although additional studies may be useful, these findings could help shape practice patterns, treatment guidelines, and payor policy in the management of patients requiring cholecystectomy. 
